Hostname: page-component-669899f699-7xsfk Total loading time: 0 Render date: 2025-04-27T04:10:06.376Z Has data issue: false hasContentIssue false
  • English
  • Français

Preparation and characterization of purified Na-activated bentonite from Karak (Pakistan) for pharmaceutical use

Published online by Cambridge University Press:  09 July 2018

L. A. Shah ,
N. S. Khattak ,
M. G. S. Valenzuela ,
A. Manan  and
F. R. Valenzuela Díaz
L. A. Shah*
Affiliation:
Institute of Physics & Electronics, University of Peshawar, Peshawar-25120, KPK, Pakistan
N. S. Khattak
Affiliation:
Dean Faculty of Science & IT, Sarhad University of Science & IT, Peshawar, KPK, Pakistan
M. G. S. Valenzuela
Affiliation:
Centro Universitário Estacio Radial de São Paulo, 05107-001, São Paulo-SP, Brazil Polytechnic School, University of Sao Paulo, 05508-900, São Paulo-SP, Brazil
A. Manan
Affiliation:
Department of Physics, University of Science and Technology Bannu, KPK, Pakistan
F. R. Valenzuela Díaz
Affiliation:
Department of Physics, University of Science and Technology Bannu, KPK, Pakistan
*
*E-mail: liaqat@upesh.edu.pk
Get access Rights & Permissions [Opens in a new window]

Abstract

The purpose of this paper was to prepare purified Na- bentonite with improved properties for use in the pharmaceutical industry. Calcium bentonite from the Shagia region of Karak district, Pakistan, was activated with various proportions of sodium carbonate (2, 3, 5 and 8 wt.%) and purified by sedimentation to remove impurities, especially quartz. X-ray diffraction (XRD), and swelling volume confirmed the conversion of raw bentonite to sodium bentonite by using 5% Na2CO3. The sodium bentonite (K5) obtained by activation met the chemical and microbiological requirements set by the pharmacopeias regarding the toxic trace elemental content (Pb and As), absence of E. coli, total aerobic microbial contents and physicochemical properties such as swelling volume, pH and sedimentation volume. Therefore K5 bentonite could be designated as potentially suitable for pharmaceutical applications. The CEC, surface area, porosity, pH, gel formation and swelling volume indicated that K5 bentonite could be used in the formulation of oral suspension and in topical application.

Keywords

bentoniteKarak districtsoda activationpharmaceutical usesswelling capacityPakistan
Type
Research Article
Information
Clay Minerals , Volume 48 , Issue 4 , September 2013 , pp. 595 - 603
Copyright
Copyright © The Mineralogical Society of Great Britain and Ireland 2013

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

Article purchase

Temporarily unavailable

References

Ahmad, S.S., Barbhuiya, A., Elahi, A. & Iqbal, J. (2011) Effect of Pakistani bentonite on properties of mortar and concrete. Clay Minerals, 46, 85–92.CrossRefGoogle Scholar
Ahmad, Z. & Siddiqi, R. A. (1992) Minerals and Rocks for Industry. Geological Survey of Pakistan.Google Scholar
Alauddin, M., Qaiser, M.A., Akhter, S. M. & Khan, A. H. (1965) Mineralogy and chemistry of Dherikot clays from Campbellpur district, Rawalpindi Division. Pakistan Journal of Scientific and Industrial Research, 8, 343–346.Google Scholar
Ali, S. T. & Shah, I. (1963) Bentonite resources of Pakistan. Proceeding of the Symposium on Industrial Rocks and Minerals, Lahore, 153 pp.Google Scholar
Barrett, E.P., Joyner, L. G. & Halenda, P.P (1951) The determination of pore volume and area distributions in porous substances. I. Computations from nitrogen isotherms. Journal of the American Chemical Society, 73, 373–380.Google Scholar
Bibi, R., Shah, W. A. & Iqbal, Ch M. (2004) Effect of pH and concentration on the removal of magnesium from magnesium chloride solution by bentonite. Pakistan Journal of Scientific and Industrial Research, 47, 336–339.Google Scholar
Braun, D. B. (1994) Over the Counter Pharmaceutical Formulations. Noyes Publications, New Jersey, USA.Google Scholar
Browne, J.E., Feldkamp, J.R., White, J. L. & Hem, S. L. (1980) Characterization and adsorptive properties of pharmaceut ical grade clays. Journal of Pharmaceutical Sciences, 69, 816–823.Google Scholar
Cara, S., Carcangiu, G., Padalino, G., Palomba, M. & Tamanini, M. (2000) The bentonites in pelotherapy: thermal properties of clay pastes from Sardinia (Italy). Applied Clay Science, 16, 125–132.Google Scholar
Carretero, M. I. & Pozo, M. (2009) Clay and non-clay minerals in the pharmaceutical and cosmetic industries. Part I. Excipients and medical applications. Applied Clay Science, 46, 73–80.Google Scholar
Carretero, M. I. (2002) Clay minerals and their beneficial effects upon human health. A review. Applied Clay Science, 21, 155–163.CrossRefGoogle Scholar
Carretero, M. I. & Pozo, M. (2010) Clay and non-clay minerals in the pharmaceutical and cosmetic industries. Part II. Active ingredients. Applied Clay Science, 47, 171–181.CrossRefGoogle Scholar
Carretero, M.I., Gomes, C.S.F. & Tateo, F. (2006) Clays and human health. Pp. 717–741 in: Handbook of Clay Science (Bergaya, F., Theng, B.K.G. & Lagaly, G., editors). Development in Clay Science, Elsevier, Amsterdam.Google Scholar
Chapman, H. D. (1965) Cation exchange capacity. Pp. 891–901 in: Methods of Soil Analysis, Part 2 (Black, C.A., editor). American Society of Agronomy, Madison, Wisconsin.Google Scholar
Cornejo, J. (1990) Las arcillas en formulaciones farmacéuticas. Pp. 51–68 in: Conferencias de la IX y X Reuniones de la Sociedad Española de Arcillas (Galán, E. & Ortega, M., editors). SEA, Madrid.Google Scholar
European Pharmacopoeia (2005). Bentonite. p. 1068 in: European Pharmacopoeia, 5th edition. European Pharmacopoeia Convention, Strasbourg, France.Google Scholar
Ferrand, T. & Yvon, J. (1991) Thermal properties of clay pastes for pelotherapy. Applied Clay Science, 6, 21–38.CrossRefGoogle Scholar
Fielden, K. E. (1996) Water-dispersible Tablets. US patent no. 5556639.Google Scholar
Galán, E., Liso, M. J. & Forteza, M. (1985) Minerales utilizados en la industria farmacéutica. Boletin de la Sociedad Espanola de Mineralogia, 8, 369–378.Google Scholar
Gamiz, E., Linares, J. & Delgado, R. (1992) Assessment of two Spanish bentonites for pharmaceutical uses. Applied Clay Science, 6, 359–368.Google Scholar
Gregg, S. J. & Sing, K.S.W (1982) Adsorption, Surface Area and Porosity. Academic Press, New York.Google Scholar
IARC (1987) IARC Monographs on the Evaluation of Carcinogenic Risks of Chemicals to Humans. Overall evaluation of carcinogenicity. IARC Scientific Publications, Lyon, France, 29 pp.Google Scholar
IARC (1997) Silica. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, IARC Scientific Publications, Lyon, France, 41 pp.Google Scholar
Khan, M. A. (2012) Phase and Microstructure of Bentonite from Khyber Pakhtunkhwa (Pakistan). M.Phil Thesis, University of Peshawar, Pakistan.Google Scholar
Khan, S.A., Rehman, U. R. & Khan, M. A. (1994) Sorption of cesium on bentonite. Waste Management, 14, 629–642.Google Scholar
Khan, S.A., Rehman, U. R. & Khan, M. A. (1995) Adsorption of chromium(iii), chromium(vi) and silver(i) on bentonite. Waste Management, 15, 271–282.CrossRefGoogle Scholar
Kibbe, A.H. (2000) Handbook of Pharmaceutical Excipients. American Pharmaceutical Association, Washington, DC.Google Scholar
Lim, C.H & Jackson, M. L. (1986) Expandable phyllosilicate reaction with lithium on heating. Clays and Clay Minerals. 34, 346–352.Google Scholar
Lopez-Galindo, A. & Viseras, C. (2004) Pharmaceutical and cosmetic application of clays. Pp. 267–289 in: Clay Surfaces: Fundamentals and Applications (Wypych, F. & Satyanarayana, K.G., editors). Elsevier, Amsterdam.Google Scholar
López-Galindo, A., Viseras, C. & Cerezo, P. (2007) Compositional, technical and safety specifications of clays to be used as pharmaceutical and cosmetic products. Applied Clay Science, 36, 51–63.Google Scholar
Luckham, P. F. & Rossi, S. (1999) The colloidal and rheological properties of bentonite suspensions. Advances in Colloid and Interface Science, 82, 43–92.CrossRefGoogle Scholar
Memon, S.A., Arsalan, R., Khan, S. & Lo, T. Y. (2012) Utilization of Pakistani bentonite as partial replacement of cement in concrete. Construction and Building Materials, 30, 237–242.CrossRefGoogle Scholar
Mirza, J., Riaz, M., Naseer, A., Rehman, F., Khan, A. N. & Ali, Q. (2009) Pakistani bentonite in mortar and concrete as low-cost construction material. Applied Clay Science, 45, 220–226.Google Scholar
Murray, H. H. (2000) Traditional and new applications for kaolin, smectite, and palygorskite: a general overview. Applied Clay Science, 17, 207–221.Google Scholar
Nasreen, S., Zubair, M., Siddiqi, F.A., Qaiser, M. A. & Khan, A. H. (1989) Studies on some indigenous materials for their puzzolanic properties. Journal of Islamic Academy of Sciences, 2, 172–176.Google Scholar
Parfitt, K. (1999) Martindale: The Extra Pharmacopoeia, 32nd ed. The Pharmaceutical Press, London.Google Scholar
Poensin, D., Carpentier, P.H., Fechoz, C. & Gasparini, S. (2003) Effects of mud pack treatment on skin microcirculation. Joint Bone Spine, 70, 367–370.CrossRefGoogle ScholarPubMed
Reinbacher, W. R. (1999) A brief history of clay in medicine. Clay Minerals Society News, 11, 22–31.Google Scholar
Saleemi, A. A. & Ahmed, Z. (2000) Mineral and chemical composition of Karak mud stone, Kohat Plateau, Pakistan: implications for smectite illitization and provenance. Sedimentary Geology, 130, 229–247.Google Scholar
Sanchez, C.J., Parras, J. & Carretero, M. I. (2002) The effect of maturation upon the mineralogical and physicochemical properties of illitic-smectitic clays for pelotherapy. Clay Minerals, 37, 457–464.Google Scholar
US Pharmacopoeia (2007a) Bentonite. P. 1066 in: US Pharmacopoeia 30 and National Formulary 25. US Pharmacopoeial Convention, Rockville, MD, USA.Google Scholar
US Pharmacopoeia (2007b) Microbial limit test. P. 83 in: US Pharmacopoeia 30 and National Formulary 25. US Pharmacopoeial Convention, Rockville, MD, USA.Google Scholar
US Pharmacopoeia (2007c) Purified bentonite. P. 1067 in: US Pharmacopoeia 30 and National Formulary 25. US Pharmacopoeial Convention, Rockville, MD, USA.Google Scholar
Veniale, F. (1997) Applicazioni e utilizzazioni medicosanitarie di materiali argillosi (naturali e modificati). Pp. 205–239 in: Argille e minerali delle argille. Guida alla definizione di caratteristiche e propietà per gli usi industriali. Corso di Formazione (Morandi, N. & Dondi, M., editors). Gruppo Italiano AIPEA, Rimini, Italy.Google Scholar
Veniale, F., Bettero. Jobstraibizer, A. & Setti, M. (2007) Thermal muds: perspectives of innovations. Applied Clay Science, 36, 141–147.Google Scholar
Viseras, C. & Lopez-Galindo, A. (1999) Pharmaceutical applications of some Spanish clays (sepiolite, palygorskite, bentonite): some preformulation studies. Applied Clay Science, 14, 69–82.Google Scholar
Viseras, C., Ferrari, F., Yebra, A., Rossi, S., Caramella, C. & López-Galindo, A. (2001) Disintegrant efficiency of special phyllosilicates: smectite, palygorskite, sepiolite. STP Pharma Sciences, 11, 137–143.Google Scholar
Viseras, C., Cultrone, G., Cerozo, P., Aguzzi, C., Baschini, M.T., Valles, J. & Lopez-Galindo, A. (2006) Characterization of northern Patagonian bentonites for pharmaceutical uses. Applied Clay Science, 31, 272–281.Google Scholar
Viseras, C., Aguzzi, C., Cerezo, P. & Lopez-Galindo, A. (2007) Uses of clay minerals in semi-solid health care and therapeutic products. Applied Clay Science, 36, 37–50.Google Scholar
Viseras, C., Cerezo, P., Sanchez, R., Salcedo, I. & Aguzzi, C. (2010) Current challenges in clay minerals for drug delivery. Applied Clay Science, 48, 291–295.Google Scholar
Wai, K.N., Dekay, H. G. & Banker, G. S. (1966) Applications of the montmorillonites in tablet making. Journal of Pharmaceutical Sciences, 55, 1244–1248.Google Scholar
Yildiz, N. & Calimli, A. (2002) Alteration of Three Turkish Bentonites by Treatment with Na2CO3 and H2SO4 . Turkish Journal of Chemistry, 26, 393–401.Google Scholar